Portfolio Manager Factsheet

July 2019

Healthcare stocks were more turbulent and despite moving higher in GBP terms, finished lower in July in USD terms. The main culprit was unexpected news flow on U.S. drug price reforms from the Trump administration . Two additional stocks with outsized gains in the month included the medical device company, Edwards Lifesciences and the specialty pharmaceutical company, Neurocrine Biosciences. Both stocks were higher after better than expected quarterly reports in July. 
 

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.